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1. Introduction 
 Lactic acid bacteria (LAB) are a heterogeneous group of bacteria widely distributed in 
nature. These bacteria are found in gastrointestinal (GI) and urogenital tract of humans and 
animals; they are present on plant material, in milk and meat, and numerous fermented 
foods. Lactic acid bacteria have been associated with traditional dairy products, cereals, 
vegetable and meat fermented foods, due to their natural presence leading to spontaneous 
fermentation. They are also used as starter cultures in industrial food production, as well as 
in the production of probiotic products due to their potential health benefits to consumer. 
Milk and dairy products are the most examined food system for the delivery of probiotic 
bacteria to the human gut. The probiotic concept has progressed and is now in the focus of 
different research. Significant improvements have been made in selection and 
characterization of new cultures and their application in food production.  
The food products, which are produced by traditional methods, exhibit a rich biodiversity 
with the respect to bacterial contents. From these products, new probiotic strains with the 
potential functional properties can been isolated and selected. The selected strains have to 
be further characterized in order to be used in the food industry. Before the probiotics can 
benefit human health, they must fulfill several criteria including: a) scientifically validated 
health properties; b) good technological properties meaning that they can be manufactured 
and incorporated into food products without loosing viability, functionality and technological 
performance; c) high survival through the upper gastrointestinal tract and high viability at 
its site of action; d) antagonistic activity to pathogens; e) antibiotic susceptibility; and f) to be 
able to function in the gut environment. Bearing in mind importance of antibiotic resistance 
of LAB in food chain, antibiotic susceptibility of potential probiotic strains is a very 
important criteria for their selection. 
In the recent decade, releasing of antibiotics in biosphere seriously increased, leading to a 
strong selective pressure for the emergence and persistence of resistant LAB strains. Since 
LAB are naturally present in traditionally made fermented food and GI tract and are also 
added as starter culture or probiotic bacteria in industrial food production, concerns have 
been raised about the antibiotic resistance of these beneficial bacteria strains. Probiotic 
bacteria can help maintaining balance in gastrointestinal tract in cases of diarrhea caused by 
antibiotic treatment. However, there is high risk associated with the ability of these resistant 
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strains to transmit the resistance gene to pathogenic bacteria in gut microbiota. This can 
complicate the treatment of a patient with an antibiotic resistant bacterial infection or 
disease. The circulation of genes coding for antibiotic resistance from beneficial LAB in the 
food chain via animals to humans is a complex problem. Therefore, there is a need to evaluate 
the safety of potential probitic strains regarding their ability to acquire and disseminate 
antibiotic resistance determinants in selection of LAB. 
In this study, importance of LAB in the food chain will be reviewed. Morphological and 
biochemical characteristics of lactobacilli, bifidobactera and enterococci, as well as criteria 
for probiotic selection and role of probiotics in health benefit will be discussed. Antibiotic 
susceptibility as criteria for potential probiotic bacteria selection and mechanisms of gene 
transfers will be considered.  
2. Lactic acid bacteria in the GI tract 
The human GI tract represents a complex ecosystem in which interactions between food, 
microbes and the host cells occur. The bacterial population of normal gut of an adult 
comprise of more than 500 different species. The quantity of microbes present in the 
intestine (about 1014) exceeds 10-fold the total number of all human cells (Backhed et al., 
2005). The most important function of this intestinal microbiota is to act as a microbial 
barrier against pathogens, by so-called competitive exclusion mechanisms, but also 
influence the humoral and cellular mucosal immune responses during the neonatal phase of 
life, and thereafter to maintain a physiologically-normal steady-state condition throughout 
life (Tancrede, 1992). The gut microflora profoundly influences nutritional, physiologic and 
protective processes. Both direct and indirect defensive functions are provided by the 
normal microbiota. Specifically, gut bacteria directly prevent colonization by pathogenic 
organisms by competing for essential nutrients or for epithelial attachment sites. By 
producing antimicrobial compounds, volatile fatty acids, and chemically modified bile acids, 
indigenous gut bacteria also create a local environment that is generally unfavourable for the 
growth of enteric pathogens. This phenomenon is called Colonization Resistance, which can be 
defined as the ability of microorganisms belonging to the normal gut microflora to impede the 
implantation of pathogens (van der Waaij, 1988). This function of the microflora is also known 
as the barrier effect. While probiotic bacteria improve colonization resistance, consensus 
thinking is that the importance of LAB as probiotic agents lies more in the indirect 
mechanisms such as immunomodulation. When the genetic repertoire of these bacteria is 
considered, the GI tract translates into a reservoir of genes encoding numerous 
physiological functions from which the human GI tract can benefit. Bacteria represent the 
most extensively investigated group of microorganisms. Which species of bacteria will be 
long-term colonized in GI tract depends on the biochemical capability of the 
microorganisms, the microenvironment determined by the host cells and the available 
foodstuffs. Lactobacilli are probably the most well known representative of favourable 
microorganisms in GI tract. There is a number of species of lactobacilli reside in the human 
intestine in a symbiotic relationship with each other and with other microorganisms 
(Claesson et al., 2007). They are generally considered essential for maintaining gut 
microfloral health; however, it is the overall balance of the various microorganisms which is 
ultimately of most importance. 
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2.1 The composition of the GI tract 
The composition of the GI microflora undergoes considerable changes from the day of birth 
until adulthood. The GI tract of a normal fetus is sterile, but colonization begins 
immediately after birth and is influenced by the mode of delivery, the infant diet, hygiene 
levels and medication (Benett et al., 1986; Gronlund et al., 1999). During the first months of 
life diet has a significant influence on the development of the intestinal flora (Heavey & 
Rowland, 1999; Stark & Lee, 1982). Within one to two days facultative anaerobes 
predominate and create a reduced environment that allows the growth of strict anaerobes. 
Within three to four days, bifidobacteria appear and become predominant. The average 
number of bifidobacteria in breast-fed infants is 1010–1011 cfu/g. In formula fed infants, 
bifidobacteria have also been demonstrated to be a numerically important species, but they 
generally occur in lower numbers than in breastfed infants of the same age (Mountzouris et 
al., 2002). The predominance of beneficial bacteria in the gut microbiota of breast-fed infants 
is thought to result from the fermentation of oligosaccharides-non-digestible carbohydrates 
consisting of several linked monosaccharides (typically 3-10 simple sugars) in breastmilk 
(Agostoni et al., 2004). Oligosaccharides pass unabsorbed through the small intestine into 
the colon, where they are fermented by resident bifidobacteria to short-chain fatty acids and 
lactic acid, reducing the gut pH to approximately 5.7, thus providing the protection against 
enteric infections (Newburg, 2000, Coppa et al., 2004). In contrast, the gut microflora of 
formula-fed infants produces a different profile of short-chain fatty acids and a pH in the 
local microenvironment of approximately 7.0 (Ogawa et al., 1992). Infant faecal flora appears 
to be stabilized at 4 weeks of age and until weaning when introduction of solid foods takes 
place (Mountzouris et al., 2002). During weaning, bifidobacteria decrease by 1 log, the 
microbiota alters from infant-type to adult-type, and a remarkable proliferation of bacteroides, 
eubacteria, peptostreptococcaceae, and clostridia occur. The faecal flora of children closely 
resembles that of adults, where the numbers of bacteroidaceae, eubacteria, peptococcaceae, 
and usually clostridia outnumbered bifidobacteria, which constitute 5-10% of the total flora. 
An adult individual’s GI tract is extremely stable and it is very difficult to introduce new 
species. There are several factors that can alter the composition of the GI flora such as 
medications (especially antibiotics), diet, climate, aging, illness, stress, pH, infections, 
geographic location, and even race (Murphy et al., 2009). Thus it is not surprising to find out 
that the composition of the GI flora not only differs among individuals, but also differs during 
the life within the same individual. Furthermore, indigenous bacteria are not distributed 
randomly throughout the gastrointestinal tract but instead are found at population levels and 
in species distributions that are characteristic of specific regions of the tract.  
As shown in Figure 1, there are three main regions that offer very different conditions for 
the survival of various microorganisms in the GI environment. In the stomach, microbial 
growth is greatly reduced by the high acidity and presence of oxygen provided by the 
swallowing. As a result, in the stomach acidotolerant microorganisms and facultative 
anaerobes such as lactobacilli, streptococci, yeasts, etc. are present. In the second region 
(small intestine), the microflora consists mainly of facultative anaerobic bacteria such as 
lactobacilli, streptococci and enterobacteria, and anaerobes such as bifidobacteria, 
bacteroides and clostridia. In the last region (colon), the number of bacteria is considerably 
high, due to the low redox potential and relatively high concentration of short-chain fatty 
acid, and counts 109–1012 cfu/ml (Cummings et al. 1989). The colon has an important role in 
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food digestion, and microflora in this region participates in the transformation of many 
carbohydrates, proteins and amino acids. The microflora of the colon is very complex and 
dominated by anaerobic bacteria (Bacteroides spp., Clostridium spp, Bifidobacterium spp., etc), 
while the facultative anaerobic bacteria are less numerous and represented by lactobacilli, 
enterococci, streptococci and Enterobacteriaceae. Yeasts (eg., Candida albicans) are relatively 
poorly represented. 
 
Fig. 1. The average concentration of microorganisms in the GI tract (adapted from 
Ouwehand & Vesterlund, 2003) 
As part of gut microbiota, it is estimated that lactobacilli are present in following 
concentrations: 103–106 cfu/ml in the oral cavity; 103 cfu/ml in the stomach; 104 cfu /ml in 
the duodenum and jejunum; 108 cfu /ml in the ileum and 109 cfu /ml in the colon (Reuter, 
2001; Koll et al., 2008; Ryan et al., 2008). An overview of lactobacilli commonly found in the 
GI tract microbiota is shown in Table 1. 
Considering that lactobacilli and bifidobacteria constitute a significant population in the GI 
tract, this environment represents a good source for the isolation of new strains of LAB. 
3. Lactic acid bacteria as probiotic bacteria 
By definition probiotics are described as „living microorganisms, which upon ingestion in 
certain numbers, exert health benefits beyond inherent basic nutrition“ (Guarner & 
Schaafsma, 1998). Regarding the probiotics, the majority of research is focused on bacterial 
genera Lactobacillus and Bifidobacterium (Table 2). 
Small intestine 
104-108 cfu/ml 
Lactobacillus 
Streptococcus 
Enterobacteria 
Bacteroides 
Clostridum 
Stomach 
101-104 cfu/ml 
Helicibacter pylori, 
Lactobacillus  
Streptococcus  
Candida albicans 
Colon
109-1012 cfu/ml 
Bacteroides 
Bacillus 
Eubacterium 
Bifidobacterium 
Clostridium 
Peptococcus 
Peptostreptococcus 
Ruminococcus 
Actinomyces 
Lactobacillus 
Enterobacteriacae 
Enterococcus 
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Oral cavity Stomach Small intestine Faeces 
Colon epithelial 
biopsies 
L. paracasei L. gasseri L. gasseri L. gasseri L. plantarum 
L. rhamnosus L. reuteri L. reuteri L. paracasei L. rhamnosus 
L. fermentum L. ruminis L. rhamnosus L. ruminis L. paracasei 
L. plantarum   L. reuteri  
L. gasseri   L. plantarum  
   L. salivarius  
   L. sakei  
Table 1. Lactobacillus species distribution in different parts of the GI tract (Lönnermark, 2010) 
 
Lactobacillus sp. Bifidobacteriim sp. Enterococcus sp. Others 
L. acidophilus B. bifidum E. faecium Lactococcus lactis ssp. lactis 
L.plantarum B. infantis E. faecalis Lactococcus lactis ssp. cremoris 
L. casei B. adolescentis  Leuconostoc mesenteroides 
L. rhamnosus B. longum  Pediococcus acidilactici 
L. delbrueckii ssp. bulgaricus B. breve  Propionibacterium freudenreichii 
L. fermentum B. lactis  Streptococcus thermophilus 
L. johnsonii    
L. gasseri    
L. salivarius     
L. reuteri    
Table 2. Lactic acid bacteria used as probiotics (adapted from Gardnier et al., 2002) 
They have a reputation of health promoters and they have a significant role as probiotic 
bacteria in the production of different foods, particularly in the production of fermented 
dairy products. Central position of lactobacilli and bifidobacteria in probiotic formulation is 
argumented due to (a) the association of these bacteria with human health, (b) the fact that 
they possess the Generally Regarded As Safe (GRAS) status. Enterococci, although not 
GRAS organisms, have been used as probiotics too. Some other LAB such as lactococci, 
pediococci, Leuconostoc, propionibacteria have also received attention as potential probiotic 
cultures (Table 2). 
3.1 Lactobacillus 
The genus Lactobacillus is large heterogeneous group of microorganisms, which lacks 
catalase and cytochromes and is usually microaerophilic, with growth improved under 
anaerobic conditions (Kandler & Weiss, 1989). They are Gram-positive nonmotile rods, often 
in pairs or chains, coccobacilli to long rods. They have a strictly fermentative metabolism 
and convert glucose solely or partly to lactic acid. They are classified as homofermentative 
(producing mainly lactic acid) or heterofermentative (producing carbon dioxide, ethanol, 
acetic acid and lactic acid). The optimum growth temperature is in the mesophilic range (30-
40ºC), but some strains can grow below 15ºC and some at temperatures up to 55ºC. 
Differentiation of Lactobacillus species depends on physiological criteria, carbohydrate 
fermentation, biochemical and molecular characterization (Petrovic et al., 2006). Lactobacilli 
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play crucial role in the production of fermented foods: vegetables, meats and dairy 
products. Non starter lactic acid bacteria (NSLAB) are lactobacilli which form significant 
proportion of the microflora of most cheese varieties during ripening. Many species of 
mesophilic Lactobacillus have been isolated from cheese; the ones most frequently 
encountered are L. casei, L. paracasei, L. pantarum, L. rhamnosus and L. curvatus (Beresford et 
al., 2001). For example, L. plantarum, L. casei ssp. casei and L. brevis have been isolated from 
Armada cheese, a Spanish goat milk cheese (Herreros et al., 2003), L. plantarum, L. 
paraplantarum, L. paracasei ssp. tolerans, L. sake, L. curvaus and L. pentosus from Batzos, a 
traditional Greek cheese made from raw goat′ s milk (Psoni et al., 2003) and L. para.paracasei, 
L. plantarum, L. curvatus and L. brevis from Sjenica cheese, traditional Serbian white brined 
cheese (Radulović, 2010). Traditional homemade dairy products have great potential for 
isolation of new strains, which could be used as starter cultures in food industry, as adjunct 
cultures for improving flavour of cheeses, or as probiotic in production of functional foods. 
3.2 Bifidobacterium 
Species from the genus Bifidobacterium are generally characterized as Gram-positive, non-
spore forming, nonmotile and catalase negative. They are strict anaerobes, although some 
species and strains may tolerate oxygen in the presence of carbon dioxide. Within the genus 
Bifidobacterium pleomorphism exists and it is described as short regular, thin cells with 
pointed ends, long cells with slight bends with a large variety of branching; single or in 
chains of many elements; in star-like clusters or disposed in “V” or palisade arrangements 
(Scardovi, 1986). In bifidobacteria, glucose catabolism occurs through the fructose 6-
phosphate phodphoketolase pathway, which can be used as distinguishing feature of 
bifidobacteria. During fermentation, acetic and lactic acids are produced in molar ratios 3:2. 
The optimum temperature for growth is 31-41ºC within the range 25-45ºC. Bifidobacteria are 
less acid tolerant than lactobacilli and no growth occurs at pH values less than 4.5 (Scardovi, 
1986). Nutritional requirements for growth of bifidobacteria are less complex than those of 
lactobacilli, but in some cases bifidobacteria do require specific factors for optimal growth 
(Modler et al., 1990). Bifidobacteria are natural habitants of GI tract and strains with 
probiotic properties are mainly of human origin. Bifidobacterium species constitute a 
significant portion of probiotic cultures used in functional food production.  
3.3 Enterococcus 
Although lactobacilli and bifidobacteria are most commonly used as probiotics, some 
enterococci can also be used as health-promoting bacteria. Species E. faecium and E. faecalis 
have been used as probiotic bacteria, although they are not recognized as GRAS organisms. 
All species of genus Enterococcus are Gram-positive, non-spore forming, catalasa negative, 
facultative anaerobes. They are spherical or ovoid cocci in pairs or short chains. Their 
properties, such as the ability to grow at 10ºC and 45ºC in 6.5%NaCl and at pH 9.6 and their 
survival heating to 60ºC for 30 min, are used to differentiate enterococci from other Gram-
positive catalase-negative cocci (Franz et al., 1999). Enterococci are homofermentative with 
respect to glucose metabolism, although some amounts of formic and lactic acid may be 
produced in some media. As the other LAB, enterococci do require B vitamins, amino acids, 
purine and pyramidine bases for optimal growth (Garg & Mital, 1991).  
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3.4 LAB associated with therapeutic properties 
In recent years an increasing number of probiotic pharmaceutical preparations as well as 
food supplements are being promoted with health claims. The application of LAB has been 
more developed for the production of functional foods, where probiotic bacteria have an 
important role. The commercial probiotic strains, used in functional food production, must 
be well-substantiated with scientific evidence.  
The health benefits of probiotic bacteria can be considered as nutritional or 
therapeutic/prophylactic. Nutritional benefits are mainly connected with their role in 
enhancing the bioavailability of vitamins and minerals, and an increase of the digestibility of 
protein (Tamime et al., 2003). Many researchers (Begley et al., 2006; Ouwehand et al., 2003; 
Rodrigeuz et al., 2010) investigated the therapeutic/prophylactic benefits of probiotics and 
confirmed their effects: 
- Prevention of diarrhoea caused by certain pathogenic bacteria and viruses; 
- Regulation of intestinal microflora after an antibiotic therapy; 
- Treating the infection with Helicobacter pylori, responsible for the development of 
gastritis, ulcers and gastric cancer; 
- Improvement of digestion in "lactose-intolerant" individuals, who have reduced 
capability for lactose digestion;  
- Anticancer effect, as a result of the production of certain compounds during its growth;  
- Reducing cholesterol levels;  
- Stimulation of -interferon production, which contributes to increased resistance to 
some infections;  
- Increasing antibody titar (IgG immunoglobulins), which enhances the immune 
response of an organism; 
Health effects are related to microflora modification and strengthening of the gut mucosal 
barrier. Some scientific data indicated that probiotic strains have potential in the prevention 
and treatment of intestinal and urogenital infections and these cultures may be useful as an 
alternatives to antibiotic therapy. The World Health Organization (WHO) has recommended 
the reconsideration of microbial interference therapy for infection control (Bengmark, 1998). 
Certain probiotic strains have been shown multiple effects including prevention of pathogen 
attachment and invasion in cell culture, inhibiting of the growth of enteropatogens in vitro 
and enhancement the immune response. Considering thee effects, the usage of probiotics 
may decrease antibiotics dependence. Fooks et al., (1999) have suggested that probiotic 
bacteria can control the infection in several ways such as the competition for nutrients, 
secretion of antimicrobial substances, reduction of pH, blocking of adhesion sites, reduction 
of virulence, blocking of toxin receptor sites, immune stimulation and suppression of toxin 
production.  
Infections by bacterial or viral agents most frequently result in diarrhea. One of the most 
investigated probiotic, L.rhamnosus GG, has been very effective in the treatment of viral 
diarrhea in children, most cases of which were caused by rotavirus. Other probiotic strains 
such as Lactocacillus casei Shirota, B. bifidum and S. thermophillus have also been shown to be 
effective in the treatment and prevention of rotavirus diarrhea in children (Korhonen, et al., 
2007; Saavedra et al., 1994). 
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Antibiotic-associated diarrhea (AAD) is a major clinical problem that occurs following 
antibiotic use. The most serious form of this kind is pseudomembranous colitis. Diarrhea is 
caused by pathogen overgrowth and in 20% cases the etiological agent is Clostridium difficile, 
a pathogen that is especially persistent and difficult to treat (Lewis & Freedman, 1998). 
Antibiotics are often used to treat for pseudomembranous colitis or other AAD, although 
the relapse may occurs when the probiotic therapy may be especially useful. Oral therapy 
with L. rhamnosus GG was effective in the prevention of AAD, in treatment of colitis, as well 
as in traveller's diarrhea (Shah, 2007). A combination of B. bifidum, S. thermophilus, L. 
delbrueckii spp. bulgaricus and L. acidophilus have been also effective in the prevention of 
traveller's diarrhea (Black et al., 1989).  
On the other hand, many studies have shown no effect of probiotic treatment (Lewis & 
Freedman, 1998). There is still some doubts regaring the quality and efficacy of probiotic 
products. Nevertheless, the probiotic food industry is flourishing. In many European 
counties the market is expanding resulting in sell of probiotic yogurts that account for over 
10% of all yogurts sold in Europe (Stanton et al., 2001).  
4. Criteria associated with probiotic bacteria 
Consortium of LAB constitute a major part of the natural microflora of human intestine and 
when present in sufficient numbers create a healthy equilibrium between beneficial and 
potentially harmful microflora in the gut (Dune et al., 2001). For some positive effects on 
human health, a probiotic strain has to reach the large intestine at a concentration of about 
107 viable cells/g (Stanton et al., 2001). Microorganisms ingested with food begin their 
journey to the lower intestinal tract via the mouth and are exposed during their transit 
through the GI tract to successive stress factors that influence their survival. The time from 
entrance to release from the stomach is about 90 min, but further digestive processes have 
longer residence times (Berrada et al., 1991). Probiotic bacteria must overcome physical and 
chemical barriers in the GI tract, especially acidic environment of the stomach, and then the 
activity of hydrolytic enzymes and bile salts in the small intestine. In a typical acid tolerance 
tests, the viability of potential probiotic organisms is determined by exposing them to low 
pH in a buffer solution or medium for a certain period of time, during which the number of 
surviving probiotic bacteria is determined. The generally requirements for probiotics are 
shown in Table 3. 
 
Acid and bile stability 
Adherence to human intestinal cells 
Ability to reduce the adhesion of pathogens to surfaces 
Colonization of human GI tract 
Antagonism against carcinogenic and pathogenic bacteria 
Production of anti-microbial substances 
Survive the various technological processes of production 
Safety evaluation: nonpathogenic, nontoxic, nonallergic, nonmutagenic 
Desirable metabolic activity and antibiotic resistance/sensitivity 
Clinically validated and documented health effects 
Table 3. The desired properties of probiotic strains (adapted from Mattila & Sarraela, 2000) 
www.intechopen.com
 
Antibiotic Susceptibility of Probiotic Bacteria 
 
557 
Bile plays an essential role in lipid digestion; it emulsifies and solubilizes lipids and 
functions as biological detergent. Prior to secretion into the duodenum, bile acids, which are 
synthesized from cholesterol, are conjugated to either glycine or taurine in liver (Begley et 
al., 2006). In the colon conjugated bile undergoes to the various chemical changes including 
deconjugation, dehydroxylation, dehydrogenation, and deglucuronidation, almost solely by 
microbial activity (Begley et al., 2006). Bile reduces the survival of bacteria by destroying 
their cell membranes, whose major components are lipids and fatty acids and these 
modifications may affect not only the cell permeability and viability, but also the 
interactions between the membranes and the environment. Bile salt hydrolases (BSHs) are 
generally intracellular, oxygeninsensitive enzymes that catalyze the hydrolysis of bile salts 
(Liong & Shah, 2005). A number of BSHs have been identified and characterized in probiotic 
bacteria (Franz et al., 2001a).  
The adhesion ability as well as interaction with pathohens is regarded as important selection 
criteria for potential probiotic strains (Salminen et al. 2010). Adhesive properties of LAB 
depend on a variety of factors, including non-specifc adhesion determined by electrostatic 
or hydrophobic forces and specific binding dependent on particular molecules. To examine 
the adhesive property of LAB, several models have been developed. These include binding 
to tissue culture cells (Tuomola & Salminen, 1998), radiolabelling (Bernet et al., 1993), 
intestinal mucus (Ouwehand et al., 2001), extracellular matrix proteins (de Leeuw et al., 
2006) and resected colonic tissue (Vesterlund et al., 2005). Although none of these models 
reflect the complex interactions occurring in the mucosal layer of the digestive tract, they 
represent a rapid method for the screening of potential probiotic strains. 
Other functional property used to characterize probiotics is the production of antimicrobial 
compounds. Several antimicrobial substances that have considerable advantages in 
competition with pathogens and other harmful bacteria are produced by LAB (Klare et al., 
2007; Radulović et al., 2010a). These substances include fatty acids, organic acids, hydrogen 
peroxide, and diacetyl, acetoin and the most studied inhibitory peptides called ‘bacteriocins’ 
(Todorov et al., 2011). The ability of probiotics to establish in the GI tract is enhanced by 
their ability to eliminate competitors. Some examples of antimicrobial substances produced 
by probiotic bacteria are presented in Table 4. 
 
Probiotic Compaund 
Lactobacillus GG Wide spread antibiotic 
L. acidophilus Acidolin,Acidophilin, Lactocidin 
L. delbrueckii ssp. bulgaricus Bulgarican 
L. plantarum Lactolin 
L. brevis Lactobacillin,Lactobrevin 
L. reuteri Reuterin 
Table 4. Antimicrobial substances (Fuller, 1992)  
Antibiotic susceptibility of potential probiotic strains is also considered as an important 
selection criterion for potential probiotic status (Hummel et al., 2007). Some LAB may carry 
potentially transmissible plasmid-encoded antibiotic resistance genes. The transmission of 
antibiotic resistance genes to unrelated pathogenic or potentially pathogenic bacteria in the 
gut is a major health concern related with the probiotic application (see detailed information 
in paragraph 6). 
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Along with above mentioned criteria, selected probiotic strains have to be able to survive 
well in the food and to have the appropriate technological properties (e.g. acidification 
during fermentation if required). In addition, it is important that the added probiotic does 
not adversely affect the taste, smell, and texture of the food or beverage.  
In vitro tests based on these selection criteria, although not a definite means of strain 
selection, may provide an useful initial information. A validation model system, such as a 
Simulator of the Human Intestinal Microbial Ecosystem (SHIME), which aims to mimic 
complex physiological and physiochemical in vivo reactions, may also be of value in strain 
selection. However, the ultimate proof of probiotic effects requires validation in well 
designed statistically sound clinical trails. Generally, tools that may be employed in such an 
assessment include in vitro studies, studies of strain properties, pharmacokinetic studies, 
animal studies, use of intestinal models, human studies and epidemiological surveillance. 
Each strain needs to be tested separately. 
It is evident that the selection of new potential probiotic bacteria is an enormous and time-
consuming task with uncertain results. 
5. Antibiotic resistance of LAB in the food chain 
During the recent years, there has been great concern about the possibility of spreading the 
antibiotic resistance in the environment. According to the European Commission (2005), it 
has been estimated that one to ten million tons of antibiotics has been released into the 
biosphere over the last 60 years. This has lead to very strong selective pressure for the 
emergence of resistant bacterial strains. Since LAB are present in the GI tract in large 
amounts, LAB resistant to certain antibiotics could benefit the host organism. Nevertheless, 
there is a risk associated with the ability of these resistant strains to transmit the resistance 
gene to pathogenic bacteria. Literature data pointed out that some LAB, the predominant 
microbiota in fermented dairy and meat products, may serve as reservoirs of antibiotic 
resistance genes potentially transferable to human pathogens (Mathur & Singh, 2005).  
The food chain could be regarded as one of the main pathways for the transmission of 
antibiotic resistant bacteria from animals to humans (Singer et al., 2003). Molecular analysis 
of resistance genes localized on transferable genetic elements showed they are identical in 
humans and animals, which confirm that food of animal origin, particularly sausages and 
cheeses made from raw milk, serve as a vehicle for the transmission of resistant bacteria and 
antibiotic resistance determinants. The antibiotics application in sub-therapeutic levels in 
animal′s drinking water and feed increases the selective pressure and amplify the transfer of 
antibiotic resistance between bacterial species. Thus there is a direct correlation between the 
indigenous microflora of the GI tract of animals with the GI tract of humans. Although 
many species of LAB used as starter and probiotic cultures possess GRAS status, potential 
risk to human health caused by the genes transfer of antibiotic resistance has not yet been 
fully defined. To address this aspect, the safety of LAB should be verified with the respect of 
their ability to acquire and disseminate resistance determinants (Kastner et al., 2006). 
Particular concern is due to the evidence of a widespread occurrence in this bacterial group 
of conjugative plasmids and transposons. The presence of transmissible antibiotic resistance 
markers in the safety evaluation of LAB strains is a very important task since genes 
conferring resistance to several antimicrobials (e.g. chloramphenicol, erythromycin, 
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streptomycin, tetracycline, and vancomycin) located on transferable genetic elements 
(plasmids or transposons) have already been characterized in lactococci (Perreten et al., 
1997), lactobacilli (Axelsson et al., 1988; Danielsen, 2002) and enterococci (Eaton & Gasson, 
2001; Huys et al., 2002) isolated from food. However, the transfer of antibiotic resistance 
genes from LAB reservoir strains to bacteria in the resident microflora of human GI tract 
and hence to pathogenic bacteria, has not been fully addressed.  
Irrespective of the antibiotic resistance mechanisms and the bacterial taxon involved, the 
possibility of spreading an antibiotic resistance determinant through horizontal transfer 
relies on its genetic basis. Therefore, a distinction between intrinsic and acquired resistance 
has to be made. Antibiotic resistance may be intrinsic for bacterial species or a genus, and it 
is characterized by the ability of an organism to survive in the presence of certain 
antimicrobial agents, due to its inherent characteristics of resistance. Intrinsic or “natural” 
resistance mechanisms involve the absence of the target, low cell permeability, antibiotic 
inactivation and the presence of efflux mechanisms. Enterococci are intrinsically resistant to 
cephalosporins and low levels of aminoglycoside and clindamycin (Teuber et al., 1999). 
Lactobacilli, pediococci and Leuconostoc spp. have been reported to have a high natural 
resistance to vancomycin, a property that is useful to separate them from other Gram-
positive bacteria (Hamilton- Miller & Shah, 1998; Simpson et al., 1988). Some lactobacilli 
have a high natural resistance to bacitracin, cefoxitin, ciprofloxacin, fusidic acid, kanamycin, 
gentamicin, metronidazole, nitrofurantoin, norfloxacin, streptomycin, sulphadiazine, 
teicoplanin, trimethoprim/sulphamethoxazole, and vancomycin (Danielsen & Wind, 2003). 
For a number of lactobacilli a very high frequency of spontaneous mutation to nitrofurazone 
(10-5), kanamycin and streptomycin was found (Curragh & Collins, 1992). From these data it 
is clear that inter-genus and inter-species differences exist, and consequently identification 
at species level is required in order to interpret phenotypic susceptibility data. Acquired 
resistance is a characteristic of some strains within a species usually susceptible to certain 
antibiotics and can be horizontally spread among the bacteria. The acquisition of antibiotic 
resistance occurs via the mutation of pre-existing genes or by horizontal transmission of 
resistance determinants. With some exception, intrinsic resistance and resistance by 
mutation are unlikely to be disseminated, although any gene responsible for intrinsic 
resistance may spread provided that it is flanked by insertion sequences (European 
Commissions); horizontally transferred genes, particularly those carried on mobile genetic 
elements, are those most likely to be transmitted (Normark & Normark, 2002). Among the 
three well-known mechanisms for horizontal gene exchange between bacteria, namely free 
DNA mediated transformation, bacteriophage induced transduction, and conjugation, the 
last is acknowledged to be the most relevant for antibiotic resistance gene transfer (Salyers, 
1995). Resistance genes are frequently carried by the mobile genetic elements involved in 
these mechanisms, such as plasmids and conjugative transposons, which can be freely 
exchanged irrespective of genus or species barriers, resulting in resistance transfer or co-
transfer (Levy, 1986). Recently it has been discovered that the so-called “mobilome” also 
involves other genetic elements: the transposon can carry integrons, which are not self-
transmissible but carry a gene encoding an integrase, which in turn mobilises resistance 
genes borne on the integron as cassettes (Clementi & Aquilanti, 2011). This mechanism 
seems to be active only in the context of resistance gene exchange and it surely determines a 
substantial increase in the horizontal mobility of these genes.  
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5.1 Procedure for antimicrobial susceptibility/resistance patterns of LAB 
As mentioned above, an intrinsic resistance and resistance by mutation are unlikely to be 
disseminated, so the risk is mainly characterized by horizontally transferred genes. 
Therefore, distinction between natural and acquired antibiotic resistance among the 
population of LAB is of a great importance. Analysis of Minimal Inhibitory Concentration 
(MIC) and their distributions in defined species/antibiotic combinations helps to 
differentiate between these two resistance mechanisms. When a bacterial strain 
demonstrates higher resistance to a specific antibiotic than the other strains of the same 
taxonomical unit, the presence of acquired resistance is indicated and there is a need for 
further analysis to confirm the genetic basis of resistance.  
According to Murray et al., (2003) the MIC distribution of a given antibiotic for a single 
bacterial species in the absence of resistance mechanisms should approach statistical 
normality while bimodal distribution of MIC values suggest acquired resistance. For the 
purpose of identifying bacterial strains with acquired and potentially transferable antibiotic 
resistance, microbiological breakpoints have been defined. Microbiological breakpoints are 
set by studying the MIC distribution in the bacterial population and the part of population 
that clearly deviates from a susceptible majority is considered resistant (Olsson-Liljequist et 
al., 1997). 
The data used for the definition of microbiological breakpoints, as reported in Table 5, were 
derived from the published body of research and from national and European monitoring 
procedures. The antibiotics listed: ampicillin, vancomycin, gentamicin, kanamycin, 
streptomycin, erythromycin, clindamycin, quinupristin+dalfopristin, tetracycline and 
chloramphenicol were chosen to maximise the identification of resistance genotypes by 
assessing the resistance phenotypes. 
In Gram-positive, bacteria acquired trimethoprim resistance, although occasionally detected 
is relatively rare. The data available (Korhonen et al., 2007) indicate that within species of 
lactobacilli the range of apparent trimethoprim resistances can be wide with no clear 
breakpoint values. Therefore, the MIC testing of trimethoprim for LAB was not considered 
relevant. Furthermore, testing for linezolid and neomycin is no longer considered necessary. 
The extremely rare non-mutational resistance to linezolid is due to the acquisition of the cfr 
gene, which also confers resistance to chloramphenicol (Arias et al., 2008; Toh et al., 2007). 
Testing for chloramphenicol resistance will efficiently cover for the hazard of acquiring 
resistance to linezolid. Neomycin is removed from the list since testing for the remaining three 
aminoglycosides efficiently covers the hazard of acquiring resistance to aminoglycosides. 
Antibiotic susceptibility testing may be performed using different phenotypic test methods. 
In Clinical and Laboratory Standards Institute (CLSI), formerly National Committee on 
Clinical Laboratory Standards (NCCLS), the approved standards state that the methods of 
choice are agar dilution and broth microdilution (Anonym, 2007). Other widely used 
methods include the agar gradient method and commercial methods, such as Etest, which 
consists of a predefined gradient of antibiotic concentrations on a plastic strip 
(AbBiomerieux, Sweden). In addition to phenotypic antibiotic resistance determinations, 
also genotypic detection of particular genes causing resistance may be performed. These 
genotypic methods include different PCR –based methods, southern hybridization, plasmid 
profiling and microarray (Ammor et al., 2008; Aquilanti et al., 2007). The situation is clearest 
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Lactobacillus obligate 
homofermentative 
1 2 16 16 16 1 1 4 4 4 
Lactobacillus helveticus 1 2 16 16 16 1 1 4 4 4 
Lactobacillus acidophilus
group 
1 2 16 16 16 1 1 4 4 4 
Lactobacillus delbrueckii 1 2 16 16 16 1 1 4 4 4 
Lactobacillus obligate 
heterofermentative 
2 n.r. 16 16 64 1 1 4 8 4 
Lactobacillus reuteri 2 n.r. 8 16 64 1 1 4 16 4 
Lactobacillus fermentum 1 n.r. 16 32 64 1 1 4 8 4 
Lactobacillus facultative 
heterofermentative* 
4 n.r. 16 64 64 1 1 4 8 4 
Lactobacillus plantarum 2 n.r. 16 64 n.r. 1 1 4 32 8 
Lactobacillus rhamnosus 4 n.r. 16 64 32 1 1 4 8 4 
Lactobacillus paracasei 2 n.r. 32 64 n.r. 1 1 4 4 4 
Bifidobacterium 2 2 64 n.r. 128 0.5 0.25 1 8 4 
Enterococcus 4 4 32 512 128 4 4 4 2 8 
Pediococcus 4 n.r. 16 64 64 1 1 4 8 4 
Leuconostoc 2 n.r. 16 16 64 1 1 4 8 4 
Lactococcus lactis 2 4 32 64 64 2 4 4 4 8 
Streptococcus thermophilus 2 4 32 64 64 2 2 4 4 4 
Bacillus spp. n.r. 4 4 8 8 4 4 4 8 8 
Propionibacterium 2 4 64 64 64 0.5 0.25 0.5 2 2 
Other Gram (-) 1 2 4 16 8 0.5 0.25 0.5 2 2 
n.r. not required; 
 *including Lactobacillus salivarius; 
 **possible interference of the growth medium 
Table 5. Microbiological breakpoints categorizing bacteria as resistant (mg L-1). Strains with 
MIC higher than the breakpoints below are considered as resistant.  
when the phenotypic and genotypic resistance patterns are in agreement. However, a 
phenotypically resistant strain may be genotypically “susceptible”. This is usually due to the 
fact that appropriate genes are not included in the test patterns, or there might be unknown 
resistance genes. Tetracycline, for example, has more than 40 different genes conferring 
antibiotic resistance discovered at the moment, and the number of tetracycline resistance 
genes continues to increase (Roberts, 2005). In contrast, a susceptible phenotype may also 
carry silent genes, which are observed with genotyping. 
However, there is still a lack of agreement on the resistance-susceptibility breakpoints for 
most antibiotics in LAB (Charteris et al., 1998; Danielsen & Wind, 2003; Katla et al., 2001). 
Generally, the choice of medium has been shown to have a profound impact on the MICs of 
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LAB. The recommended growth media by the National Committee for Clinical Laboratory 
Standards (Mueller-Hinton agar) (NCCLS, 2002) and by the British Society for Antimicrobial 
Chemotherapy (Iso-Sensitest agar) (Andrews, 2001) do not support growth of all LAB. MRS 
medium, that generally supports the growth of LAB much better, is not always compatible 
to the Iso-Sensitest medium for the use in susceptibility testing, as was reported for various 
classes of antibiotics (Huys et al., 2002). Furthermore, there are still no guidelines available 
for the interpretation of susceptibility test results of commensal or food-associated bacteria. 
Additionally, MIC breakpoints values have been shown to be species specific and thus vary 
between species of the same genera (Danielsen & Wind, 2003). Also, distinguishing between 
intrinsic, non-specific and acquired resistance is difficult and requires, besides the 
evaluation of genetic base of resistance, that the antimicrobial-resistance patterns of many 
LAB species from different sources may be compared (Teuber et al., 1999). 
5.2 Mobile genetic elements in LAB  
A prerequisite for LAB to acquire antibiotic resistance genes from other bacteria is their 
ability to communicate actively and passively with these bacteria with the aid of conjugative 
plasmids and transposons. Conjugative plasmids and transposons are common in LAB, and 
due to their wide environmental distribution, it is possible that these commensal bacteria act 
as vectors for the dissemination of antibiotic resistance determinants to the consumer via the 
food chain. Plasmids are found in many genera of LAB, characterized by different size, 
function and distribution (Davidson et al., 1996; Wang & Lee, 1997). The functions related to 
the plasmids include hydrolysis of proteins, metabolism of carbohydrates, amino acids and 
citrate, production of bacteriocins and exopolysaccharides, and resistance to antibiotics, 
heavy metals and phages. At least 25 species of lactobacilli contain native plasmids (Wang & 
Lee, 1997), and often appear to contain multiple (from 1 to 16) different plasmids in a single 
strain. R-plasmids encoding tetracycline, erythromycin, chloramphenicol, or macrolide-
lincomycin-streptogramin resistance have been reported in L. reuteri (Lin et al., 1996; 
Tannock et al., 1994), L. fermentum (Fons et al., 1997; Ishiwa & Iwata, 1980), L. acidophilus 
(Vescovo et al., 1982), and L. plantarum (Danielsen, 2002) isolated from raw meat, silage and 
faeces. The reported prevalence of antibiotic resistance genes such as erythromycin, 
vancomycin, tetracycline, chloramphenicol, and gentamicin resistance genes, on transferable 
genetic elements in enterococci is more extensive, both on plasmids (Murray et al., 1988) and 
transposons (Clewell et al., 1995; Perreten et al., 1997a; Rice & Marshall, 1994;). A multiple 
antibiotic resistance plasmid was reported in a L. lactis strain isolated from cheese (Perreten 
et al., 1997b), encoding streptomycin, tetracycline and chloramphenicol resistance.  
Conjugative transposons are the major vehicle regarding antibiotic resistance transport in 
LAB. They have been discovered in E.faecalis (Tn916, Tn918, Tn920, Tn925, Tn2702), E. 
faecium (Tn5233) and L. lactis (Tn5276, Tn5301). In enterococci and streptococci, resistances to 
tetracycline (tet (M)), erythromycin (ermAM, erm), chloramphenicol (cat) and kanamycin 
(aphA-3) have been determined. In lactococci, code for nisin (nis) production and sucrose 
fermentation (sac) has been observed. These transposons vary in size between 16 and 70 kb 
and may be inserted into plasmids or the chromosome in one or multiple copies. They may 
mobilize plasmids or chromosomal genes. The most remarkable observation is the extreme 
host range, which is the property of the Tn916/Tn1545 family.  
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5.3 Horizontal transferability of antibiotic resistance from LAB in food chain  
The possible transfer of antibiotic resistance genes between bacterial species have been 
studied mostly in harmful or pathogenic species, but also recently in LAB. The vast majority 
of the experiments have been made in vitro, using methods such as filter-mating (Klare et al., 
2007, Ouoba et al.,2008), although these in vitro methods do not mimic the circumstances in 
nature, and results obtained cannot be compared with the results achieved or expected 
using in vivo methods. The transferability of antibiotic resistance genes in the GI tract from 
LAB is not straightforward, since the GI tract is a hostile environment to many 
allochthonous bacteria. Moreover, studies made in vivo usually are based on “worst-case 
scenario”, simulating very high daily intake of food products containing the resistant 
bacteria (Jacobsen et al., 2007). The potentially transferable genes in LAB have been 
described in multiple studies and have been reviewed in Ammor et al. (2007). Two of the 
most commonly observed resistance genes in LAB found so far are tet(M) for tetracycline 
resistance and erm(B) for erythromycin, followed with cat genes coding for chloramphenicol 
resistance (Cataloluk & Gogebakan 2004; Danielsen, 2002). 
Enterococci are known to be very well receptive for conjugation (Clewell & Weaver, 1989), 
but are also successful donor organisms for the transfer of antibiotic resistance genes to 
unrelated enterococci (Rice et al., 1998), lactobacilli (Shrago & Dobrogosz, 1988), other 
Gram-positives including Bacillus subtilis (Christie et al., 1987), Staphylococcus (Young et al., 
1987) and Listeria spp. (Charpentier et al., 1997; Perreten et al., 1997b), and even Gram-
negative bacteria (Courvalin, 1994). Moreover, the transfer of conjugative elements, 
including a plasmid-encoded kanamycin resistance and a transposon-encoded tetracycline 
and erythromycin resistance (Doucet-Populaire et al., 1991), were shown to be transferable 
from E. faecalis to Escherichia coli and Listeria monocytogenes, respectively, in the digestive 
tract of mice. In contrast, reports of conjugative transfer of antibiotic resistance genes in 
other LAB are rare. Two in vivo studies were performed, to examine the possibility of 
conjugative transfer between native Gram-positive members of the gut. Therefore, the broad 
host range conjugative plasmid pAMβ1 was transferred in vitro to L. reuteri (Morelli et al., 
1988) and L. lactis (Igimi et al., 1996) and administered orally or using gastric intubation to 
mice. By analysis of faecal content, plasmid transfer to E. faecalis was observed in both 
studies.  
In order to fully understand the extent to which LAB strains transfer resistance genes in the 
natural environment, it is essential to study genetic exchange in this context. Toomey et al., 
(2009) reported on the ability of wild-type antibiotic resistance determinants [erm(B) and 
tet(M)], present in LAB strains isolated from food sources, to be transferred to recipient 
strains. In vitro mating, using a traditional filter mating technique, showed that all four LAB 
mating pairs transferred their resistance determinants at high frequencies. By employing 
two in vivo models, an alfalfa sprout plant and an animal rumen model Toomey et al.., 
(2009) demonstrated the transfer of resistance determinants between all four LAB mating 
pairs in these models. Previously, in vivo transfer between LAB has only been shown in the 
gastrointestinal tracts of gnotobiotic rats (Jacobsen et al., 2007) and mice (McConnell et al., 
1991; Morelli et al., 1988). The transfer frequencies have been observed to increase when the 
animals have received the antibiotic in question at subtherapeutic levels (Igimi et al., 1996; 
Licht et al., 2003; Salyers & Shoemaker 1996) in their drinking water or feed, suggesting that 
increasing the antibiotic pressure can amplify the transfer of antibiotic resistance between 
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bacterial species. All of these above studies indicate that antibiotic resistant factors may be 
transferred from food related bacterium species (LAB) to other, potentially pathogenic 
species. The risks associated need to be considered, in light of the increasing concerns 
related to food as a potential reservoir for antibiotic resistance determinants. 
6. Antibiotic resistance/susceptibility patterns of specific LAB genera 
applicable as probiotics 
Some features appeared to be shared by the majority of LAB; in particular, it was reported 
that most LAB species are resistant to metronidazole and that they are all intrinsically 
resistant to sulphonamides and trimethoprim, while they are usually susceptible to 
piperacillin and piperacillin plus tazobactam. On the other hand, clear differences were 
highlighted among different LAB genera, although well-defined species-specific profiles 
were not always identifiable. A high resistance to cefoxitin was acknowledged for 
Lactococcus, Leuconostoc, and Lactobacillus, whereas, as regards vancomycin, Leuconostoc, 
Pediococcus and most lactobacilli species were recognised as intrinsically resistant and most 
Lactococcus isolates as highly susceptible. 
Lactobacilli widely used in starter cultures or as probiotics in dairy products enter human 
intestines in large numbers and there interact with the intestinal microbiota (Teuber et al., 
1999). Therefore they have the potential to serve as hosts for antibiotic-resistance genes, with 
the risk of transferring the genes to opportunistic or pathogenic bacteria. Routine antibiotic 
susceptibility testing has been advocated as an essential selection criterion for potentially 
starter or probiotic Lactobacillus cultures (Charteris & Kelly, 1993). The Lactobacillus species 
have been found susceptible to many cell wall synthesis inhibitors, like penicillins and 
ampicillin (Danielsen & Wind 2003, Coppola et al., 2005), in contrast to glycopeptides such 
as vancomycin, most Lactobacillus species, excluding obligate heterofermentative species, 
have been found to be resistant to these types of antibiotics. However, the resistance 
towards vancomycin has been demonstrated being as intrinsic (Tynkkynen et al., 1998) due 
the presence of D-alanine: D-alanine ligase-related enzymes (Elisha & Courvalin, 1995) and 
should not be compared with transmissible, plasmid–mediated resistance found in 
enterococci (Leclercq et al., 1992). As a general rule, lactobacilli have a high natural 
resistance to bacitracin, cefoxitin, ciprofloxacin, fusidic acid, kanamycin, gentamicin, 
metronidazole, nitrofurantoin, norfloxacin, streptomycin, sulphadiazine, teicoplanin 
(Danielsen & Wind, 2003). In addition, resistance against inhibitors of nucleic acid synthesis, 
such as trimethoprim, seems to be intrinsic, although further characterizations are required 
on this topic (Ammor et al., 2007). Resistance to tetracycline has been observed more often 
among Lactobacillus species, and it has been shown to have a wide range of MICs (Korhonen 
et al., 2008), also with a multimodal distribution of MICs, probably due to the extensive 
variability of tetracycline resistance mechanisms conferring diverse levels of susceptibility 
(Roberts, 2005). Especially with tetracycline, molecular methods should be applied in order 
to reveal the nature of resistance, i.e. is it due to intrinsic mechanisms, mutation or added, 
mobile genes.  
Screening of antibiotic-resistance profile among Lactobacillus strains used in dairy products 
such as probiotics or as starters is now tending to become systematic. Coppola et al., (2005) 
pointed out that all of 63 L. rhamnosus strains isolated from Parmigiano Reggiano cheese 
showed resistance to six antibiotics (cefixime, vancomycin, neomycin, enoxacin, peflxacin, 
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and sulphamethoxazole plus trimetoprim). Investigating the current antibiotic-resistance 
situation in microbial food additives in Switzerland, Kastner et al., (2006) determined that 
among 74 Lactobacillus isolates applicable as starter or probiotic cultures, two antibiotic 
resistances were detected in probiotic cultures. The genetic base of those resistances was 
confirmed; the tetracycline resistance gene tet(W) in L. reuteri SD 2112 (residing on a 
plasmid) and the lincosamide resistance gene lnu(A) in L. reuteri SD 2112. The similar trend 
was noticed in study of Katla et al., (2001). Only one of the 189 Lactobacillus strains isolated 
from Norwegian dairy products such as yoghurt, sour cream, fermented milk and cheese 
was classified as high level resistant to streptomycin. In contrast, a study conducted on 
“home-made“ spanish cheese (Serena, Gamonedo, Cabrales) revealed the presence of 
lactobacilli resistant to penicillin G, cloxacillin, streptomycin, gentamycin, tetracycline, 
erythromycin and chloramphenicol (Herrero et al., 1996).  
L. lactis strains were sensitive to amikacin, ampicillin, 1st generation cephalosporin, 
chloramphenicol, erythromycin, gentamicin, imipenem, oxacillin, penicillin, pipericillin, 
sulphonamide, tetracycline, trimethoprim/sulfomethoxazole, and vancomycin (de Fabrizio 
et al., 1994). A slightly lowered susceptibility was observed towards carbenicillin, 
ciprofloxacin, dicloxacillin and norfloxacin. Intrinsic resistances were recorded towards 
colistin, fosfomycin, pipemidic acid and rifamycin. Orberg & Sandine (1985) demonstrated 
that investigated strains of L. lactis subsp. cremoris and subsp. lactis were all resistant to 
thrimethoprim and almost all to sulphathiazole. Resistance to gentamicin, kanamycin, 
lincomycin, neomycin, rifampin and streptomycin varied. 
The enterococcal strains are naturally tolerant to β-lactams, cephalosporins, lincosamides 
and polymyxins. A specific cause for concern and a factor contributing to the pathogenesis 
of enterococci is the resistance they acquire to aminoglycosides, tetracyclines, macrolides, 
chloramphenicol, penicillin, and ampicillin (Gray et al., 1991) and their capacity to exchange 
genetic information by conjugation. Enterococcal food isolates (mainly E. faecalis and E. 
faecium) were analysed for resistances to a broader range of different antibiotics using 
phenotypic susceptibility testing, both in raw meat (Knudtson & Hartman, 1993; Quednau et 
al., 1998) and fermented milk and meat products (Franz et al., 2001; Teuber & Perreten, 
2000). Their data suggest a high prevalence of (multiple) antibiotic resistant enterococci in 
foods, which nevertheless were mostly susceptible to the clinically relevant antibiotics 
ampicillin and vancomycin. Enterococci from European cheeses, mainly belonging to E. 
feacalis and E. faecium, are susceptible to different antibiotics in different proportions (Teuber 
et al., 1999; Franz et al., 2001). From the study of European cheeses Teuber et al. (1999) 
ascertained that the incidence for vancomycin resistance among enterococcal isolates was as 
low as 4%. When Franz et al. (2001) tested 47 E. faecalis strains, isolated mostly from cheeses, 
they were all susceptible to vancomycin. Bulajić & Mijačević (2011) pointed out that among 
enterococcal strains isolated from autochthonous Sombor cheese, only one strain showed 
vancomycin resistance. In contrast, Citak et al. (2004) have shown resistance to vancomycin 
among the population of enterococci isolated from Turkish white cheeses and was found in 
96.8% of E. faecalis isolates, and 76% of E. faecium strains. The susceptibility to vancomycin is 
of great importance as this glycopeptide antibiotic is one of the last therapeutic options in 
clinical therapy.  
Bifidobacteria are generally considered to be food-grade organisms that do not impose 
health risks on the consumer or the environment. Nevertheless, it should be noted that rare 
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cases of Bifidobacterium-associated gastrointestinal and extra-intestinal infections have been 
described. In contrast to susceptibility testing of clinically important bacteria, no standard 
procedures are specifically dedicated to the determination of resistance phenotypes in 
Bifidobacterium strains. To date, a large variety of methods and protocols have been 
described for antimicrobial susceptibility testing of bifidobacteria, including agar (overlay) 
disc diffusion, broth dilution and agar dilution. In addition, various growth media have 
been used primarily on the basis that they meet the complex growth requirements of 
bifidobacteria. As opposed to conventional susceptibility test media such as Mueller–Hinton 
and Iso-Sensitest medium none of these Bifidobacterium-specific media are well defined in 
terms of minimal interaction between specific antimicrobial agents and growth medium 
components. Recently, a newly defined medium formulation referred to as the Lactic acid 
bacteria Susceptibility test Medium supplemented with cysteine (LSM + cysteine) was 
proposed for susceptibility testing of bifidobacteria.  
Moubareck et al., (2005) were tested the fifty bifidobacterial strains, isolated from humans, 
animals or probiotic products for susceptibility to 30 antibiotics by disc diffusion test on 
Brucella agar supplemented with 5% laked sheep blood and vitamin K (1mg/L). All strains 
were sensitive to penicilins: penicillin G, amoxicillin, piperacillin, ticarcillin, imipenem, and 
usually anti-Gram-positive antibiotics (macrolides, clindamycin, vancomycin and 
teicoplanin). Most isolates (70%) were resistant to fusidic acid and, as expected, high 
resistance profile were observed for aminoglycosides. Potentially acquired resistance was 
only observed against tetracycline and minocycline, in 14% of the tested strains. For the first 
time, Moubareck et al., (2005) identified tet(W) as the gene responsible for tetracycline 
resistance in Bifidobacterium pseudocatenulatum and B. bifidum. Interestingly, the tet(W) gene 
was previously found in human B. longum and three genera of rumen obligate anaerobes, 
suggesting intergenic transfer of this resistance gene between anaerobic bacteria (Scott et al., 
2000). In the study of Masco et al., (2006), the LSM + cysteine medium was used to 
determine the susceptibility profile of 100 bifidobacterial isolates (strains of animal and 
human origin, isolates from probiotic products and strains from clinical sources) to 15 
common antimicrobial agents. All strains tested were susceptible to amoxicillin, 
chloramphenicol, erythromycin, quinupristin/dalfopristin, rifampicin and vancomycin. The 
date from this study (Masco et al., 2006) also reinforce earlier observations indicating that 
bifidobacteria are intrinsically resistant to gentamicin, sulfamethoxazole and polymyxin B. 
Susceptibility to trimethoprim, trimethoprim/sulfamethoxazole, ciprofloxacin, clindamycin, 
tetracycline and minocycline was variable. The tet(W) gene was responsible for tetracycline 
resistance in 15 strains including 7 probiotic isolates belonging to the taxa Bifidobacterium 
animalis subsp. lactis and B. bifidum. This gene was present in a single copy on the 
chromosome and did not appear to be associated with the conjugative transposon TnB1230 
previously found in tet(W)-containing Butyrivibrio fibrisolvens.  
7. Conclusion  
The selective pressure imposed by the use of antimicrobial agents plays a key role in the 
emergence of resistant bacteria. Under selective pressure, the numbers of these bacteria 
increase and some may transmit their resistance genes to other members of the population.. 
The food chain was considered as the main route of transmission of antibiotic resistant lactic 
acid bacteria between the animals and human population. Fermented dairy products and 
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fermented meats, which are not heat-treated before consumption, provide a vehicle for 
antibiotic resistant LAB with a direct link between the animal indigenous microflora and the 
human gastrointestinal tract. There is the potential health risk, due to the transfer of 
antibiotic resistance genes from LAB to bacteria in the human gastrointestinal tract, 
especially to pathogenic bacteria. 
Lactic acid bacteria used as starter cultures or probiotic bacteria, enter into human intestines 
in large number where they interact with the intestinal microflora. Since there has been a 
significant rise in the consumption of probiotic products, it is important that probiotics are 
well documented regarding antibiotic resistance profile. The ability to transfer antibiotic 
resistance genes must be considered as an important parameter for the selection of the 
probiotic strains. Continuous attention should be paid to the selection of probiotic strains 
free of transferable antibiotic-resistance determinants. Without doubt, the uncontrolled use 
of antimicrobial agents in farming practice has assisted the spread of resistant organisms. 
Therefore a much stricter control over the use of these drugs is essential.  
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